Epigenomics' Nine-Month Revenues Drop Sharply | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Epigenomics today reported that its nine-month revenues declined 58 percent from the comparable period in 2009.

The Berlin, Germany-based molecular diagnostics developer reported total revenues of €1.3 million ($1.8 million) for the first nine months of 2010, a sharp drop from €3.2 million for the first nine months of 2009. The firm said that the 2009 period included non-recurring payments from R&D and licensing partnerships.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.